Home LiteratureArticle Details
PMID: 8692294 Published · ppublish English Journal Article

Tolerance to nitrates and simultaneous upregulation of platelet activity prevented by enhancing antioxidant state.

Naunyn-Schmiedeberg's archives of pharmacology ·Vol. 353 ·No. 3 ·1996-02-00 ·Pages 363-7

Bassenge E, Fink B

Abstract

We analysed the induction of tolerance to nitrates both in the vasculature (in vivo) and platelets (ex vivo). Simultaneously, we tested mechanisms underlying the induction of tolerance and interventions to prevent or overcome this phenomenon. For this purpose nitroglycerin (GTN 1.5 micrograms/kg per min i.v.), alone or in combination with ascorbate (55 micrograms/kg per min i.v.) as antioxidant, was infused continuously for a period of 5 days into chronically instrumented dogs. Along with haemodynamic parameters, ex vivo platelet function was continuously monitored. Following the start of GTN infusions there was a maximal coronary dilator response (245 +/- 15 microm) and, as an index of venodilation, a fall of left ventricular end-diastolic pressure (by 2.3 +/- 0.4 mmHg). Both responses declined progressively and disappeared during the infusion period. However, in combination with ascorbate as antioxidant the dilator responses were maintained fully throughout the infusion period. With GTN alone there was a progressive, unexpected upregulation of platelet activity demonstrated by enhanced thrombin-stimulated intracellular Ca2+ levels and increases in the microviscosity of platelet membranes (indicating enhanced receptor expression) associated with a progressive impairment in basal, unstimulated cGMP levels. These changes could also be prevented completely by i.v. co-administration of ascorbate. From these results it is concluded that vascular tolerance is closely reflected by simultaneous changes in platelet function and further, that both can be prevented completely by appropriate antioxidants such as ascorbate.

MeSH Terms
Animals Antioxidants/administration & dosage,pharmacology Ascorbic Acid/administration & dosage,pharmacology Blood Platelets/cytology,drug effects,metabolism Blood Pressure/drug effects Calcium/metabolism Cyclic GMP/metabolism Dogs Drug Interactions Drug Synergism Drug Tolerance Female Infusions, Intravenous Male Muscle, Smooth, Vascular/drug effects Nitroglycerin/administration & dosage,pharmacology Thrombin/pharmacology Up-Regulation Vasodilator Agents/administration & dosage,pharmacology Ventricular Function, Left/drug effects
Chemicals
Antioxidants Vasodilator Agents Thrombin Nitroglycerin Cyclic GMP Ascorbic Acid Calcium
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Bassenge E
Institut für Angewandte Physiologie, Universität Freiburg, Germany.
Fink B
References (25)
25 references, click to expand
  1. Solving the mystery of nitrate tolerance. A new scent on the trail?
    Circulation. 1993 Jul;88(1):322-4 PMID: 8391402
  2. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance.
    J Clin Invest. 1995 Jan;95(1):187-94 PMID: 7814613
  3. Platelet cyclic GMP. A potentially useful indicator to evaluate the effects of nitroglycerin and nitrate tolerance.
    Circulation. 1993 Jul;88(1):29-36 PMID: 8391401
  4. Long-term angiotensin-converting enzyme inhibition with high-dose enalapril retards nitrate tolerance in large epicardial arteries and prevents rebound coronary vasoconstriction in vivo.
    Circulation. 1996 Jun 1;93(11):2052-8 PMID: 8640982
  5. Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin.
    Circulation. 1991 Dec;84(6):2336-45 PMID: 1835676
  6. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.
    Proc Natl Acad Sci U S A. 1990 Feb;87(4):1620-4 PMID: 2154753
  7. Protein kinase C and cyclic AMP regulate reversible exposure of binding sites for fibrinogen on the glycoprotein IIB-IIIA complex of human platelets.
    Biochem J. 1991 Jan 1;273(Pt 1):115-20 PMID: 1846526
  8. Nitrate therapy in patients with coronary artery disease--preparations and doses with and without development of tolerance.
    Z Kardiol. 1990;79 Suppl 3:57-65 PMID: 2099042
  9. Long-term nitroglycerin treatment: effect on direct and endothelium-mediated large coronary artery dilation in conscious dogs.
    Circulation. 1987 Apr;75(4):847-56 PMID: 2881635
  10. Nitrates in different vascular beds, nitrate tolerance, and interactions with endothelial function.
    Am J Cardiol. 1992 Sep 24;70(8):23B-29B PMID: 1529923
  11. Organic nitrate esters: clinical use and mechanisms of actions.
    Pharmacol Rev. 1991 Sep;43(3):351-423 PMID: 1956955
  12. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action.
    Biochim Biophys Acta. 1993 Aug 18;1178(2):153-75 PMID: 7688574
  13. Nitroglycerin metabolism in vascular tissue: role of glutathione S-transferases and relationship between NO. and NO2- formation.
    Biochem J. 1993 Jun 1;292 ( Pt 2):545-50 PMID: 8503888
  14. Nitrate tolerance in epicardial arteries or in the venous system is not reversed by N-acetylcysteine in vivo, but tolerance-independent interactions exist.
    Circulation. 1989 Jan;79(1):188-97 PMID: 2562937
  15. Inhibition of platelet function by injectable isosorbide dinitrate.
    Am J Cardiol. 1984 Jun 1;53(11):1683-7 PMID: 6428211
  16. Thiyl radical formation during thiol oxidation by ferrylmyoglobin.
    Methods Enzymol. 1995;251:106-16 PMID: 7651190
  17. Acute effects of nitroglycerin depend on both plasma and intracellular sulfhydryl compound levels in vivo. Effect of agents with different sulfhydryl-modulating properties.
    Circulation. 1993 Feb;87(2):547-53 PMID: 8425299
  18. A new generation of Ca2+ indicators with greatly improved fluorescence properties.
    J Biol Chem. 1985 Mar 25;260(6):3440-50 PMID: 3838314
  19. Altered spectrum of nitroglycerin action in long-term treatment: nitroglycerin-specific venous tolerance with maintenance of arterial vasodepressor potency.
    Circulation. 1986 Sep;74(3):573-82 PMID: 3091286
  20. Interactions of peroxynitrite with human plasma and its constituents: oxidative damage and antioxidant depletion.
    Biochem J. 1994 Oct 1;303 ( Pt 1):295-301 PMID: 7945255
  21. Mechanisms of interaction between the sulfhydryl precursor L-methionine and glyceryl trinitrate.
    Circulation. 1992 Sep;86(3):995-1003 PMID: 1355413
  22. Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance.
    Proc Natl Acad Sci U S A. 1995 May 23;92 (11):5244-8 PMID: 7539147
  23. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.
    Circ Res. 1994 Jun;74(6):1141-8 PMID: 8187280
  24. Coronary vasomotor responses: role of endothelium and nitrovasodilators.
    Cardiovasc Drugs Ther. 1994 Aug;8(4):601-10 PMID: 7531489
  25. Reaction of superoxide with glutathione and other thiols.
    Methods Enzymol. 1995;251:81-6 PMID: 7651234
Article Info
Journal
Naunyn-Schmiedeberg's archives of pharmacology
Abbr.
Naunyn Schmiedebergs Arch Pharmacol
ISSN
0028-1298
Published
1996-02-00
Pages
363-7
Language
English
Region
Germany
NLM ID
0326264
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]